Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Why Is Plus Therapeutics Stock Gaining Friday? ↗
Via Benzinga
Exposures Product Safety
News headline image
FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short ↗
Via Benzinga
Exposures Product Safety
News headline image
Securities Class Action Deadline Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Securities Class Action Deadline Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Why Is ImmunityBio Stock Rallying Thursday? ↗
Via Benzinga
Exposures Product Safety
News headline image
What's Going On With Replimune Stock Friday? ↗
Via Benzinga
Exposures Product Safety
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against ImmunityBio, Inc. (NASDAQ: IBRX) is May 26, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against ImmunityBio, Inc. (NASDAQ: IBRX) is May 26, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady ↗
Via Benzinga
Exposures Product Safety
News headline image
What to Expect From Vertex Pharmaceuticals’ Q1 2026 Earnings Report
Via Barchart.com
Topics ETFs
Exposures Product Safety
News headline image
Federal Overreach or Financial Freedom? CFTC Sues States in Landmark Bid to Shield Prediction Markets from Gambling Labels
Via MarketMinute
Topics Derivatives Fraud Intellectual Property
Tickers CME DKNG FLUT HOOD IBKR
Exposures Derivatives Ethanol Financial
News headline image
Amgen Reclaims the Lead in Thyroid Eye Disease with Superior Subcutaneous TEPEZZA Data
Via MarketMinute
Topics Intellectual Property
Tickers AMGN ARM VRDN
Exposures Intellectual Property Product Safety
News headline image
FDA Flags Quality System Lapses At Medline Facility Over Device Risks ↗
Via Benzinga
Exposures Product Safety
News headline image
Eli Lilly Just Launched Its $149 Obesity Pill ↗
Via Benzinga
Tickers LLY
Exposures Product Safety
News headline image
FDA Review Looms As Replimune Faces Weak Technical Setup ↗
Via Benzinga
Exposures Product Safety
News headline image
Invivyd Stock Surges As FDA Alignment Boosts COVID-19 Program ↗
Via Benzinga
Exposures COVID-19 Product Safety
News headline image
ImmunityBio (IBRX): From R&D Speculation to Record Commercial Revenue
Via Finterra
Topics Economy World Trade
Tickers IBRX JNJ MRK
Exposures Product Safety Supply Chain Tariff
News headline image
CORT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
3 Stocks to Buy Now for a Lifetime of Passive Income -- Starting Immediately ↗
Via The Motley Fool
Topics Product Recall
Tickers EPD O PG
Exposures COVID-19 Fossil Fuels Legal
News headline image
Kaplan Fox Encourages Investors of ImmunityBio, Inc. (NASDAQ: IBRX) to Contact the Firm Before Lead Plaintiff Deadline on May 26, 2026
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Investors of ImmunityBio, Inc. (NASDAQ: IBRX) to Contact the Firm Before Lead Plaintiff Deadline on May 26, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
Via Benzinga
Tickers JNJ
Exposures Product Safety
News headline image
The "Daily Pill" Revolution: Eli Lilly’s Orforglipron Shatters Records with 25% Weight Loss
Via MarketMinute
Tickers AMGN LLY NVO PFE
Exposures Product Safety
News headline image
CORT INVESTOR ALERT: Investors of Corcept Therapeutics, Inc. (NASDAQ: CORT) Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORT INVESTOR ALERT: Investors of Corcept Therapeutics, Inc. (NASDAQ: CORT) Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Alerts Investors of ImmunityBio, Inc. (IBRX) to a Securities Class Action Deadline on May 26, 2026
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Alerts Investors of ImmunityBio, Inc. (IBRX) to a Securities Class Action Deadline on May 26, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit ↗
Via Benzinga
Exposures Product Safety
News headline image
How One Former Financial Planner is Reshaping Financial Education for Women across Australia
Via AB Newswire
Topics Credit Cards Product Recall
Exposures Interest Rates Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.